Your browser doesn't support javascript.
loading
Heavy menstrual bleeding on direct factor Xa inhibitors: Rationale and design of the MEDEA study.
Hamulyák, Eva N; Wiegers, Hanke M G; Scheres, Luuk J J; Hutten, Barbara A; de Lange, Maria E; Timmermans, Anne; Westerweel, Peter E; Nijziel, Marten R; Kruip, Marieke J H A; Ten Wolde, Marije; Ypma, Paula F; Klok, Frederikus A; Nieuwenhuizen, Laurens; van Wissen, Sanne; Hovens, Marcel M C; Faber, Laura M; Kamphuisen, Pieter W; Büller, Harry R; Middeldorp, Saskia.
Afiliação
  • Hamulyák EN; Department of Vascular Medicine Amsterdam UMC Amsterdam Cardiovascular Sciences University of Amsterdam Amsterdam The Netherlands.
  • Wiegers HMG; Department of Vascular Medicine Amsterdam UMC Amsterdam Cardiovascular Sciences University of Amsterdam Amsterdam The Netherlands.
  • Scheres LJJ; Department of Vascular Medicine Amsterdam UMC Amsterdam Cardiovascular Sciences University of Amsterdam Amsterdam The Netherlands.
  • Hutten BA; Department of Internal Medicine Radboud University Medical Center Nijmegen The Netherlands.
  • de Lange ME; Department of Clinical Epidemiology, Biostatistics and Bioinformatics Amsterdam UMC Amsterdam Cardiovascular Sciences University of Amsterdam Amsterdam The Netherlands.
  • Timmermans A; Department of Gynecology and Obstetrics Amsterdam UMC University of Amsterdam Amsterdam The Netherlands.
  • Westerweel PE; Department of Gynecology and Obstetrics Amsterdam UMC University of Amsterdam Amsterdam The Netherlands.
  • Nijziel MR; Department of Internal Medicine Albert Schweitzer Hospital Dordrecht The Netherlands.
  • Kruip MJHA; Department of Hematology Catharina Hospital Eindhoven Eindhoven The Netherlands.
  • Ten Wolde M; Department of Hematology Erasmus University Medical Centre Rotterdam The Netherlands.
  • Ypma PF; Department of Internal Medicine Flevo Hospital Almere The Netherlands.
  • Klok FA; Department of Hematology Haga Hospital The Hague The Netherlands.
  • Nieuwenhuizen L; Department of Thrombosis and Haemostasis Leiden University Medical Centre Leiden The Netherlands.
  • van Wissen S; Department of Internal Medicine Máxima Medical Centre Veldhoven The Netherlands.
  • Hovens MMC; Department of Internal Medicine OLVG Amsterdam The Netherlands.
  • Faber LM; Department of Internal Medicine Rijnstate Hospital Arnhem The Netherlands.
  • Kamphuisen PW; Department of Internal Medicine Red Cross Hospital Beverwijk The Netherlands.
  • Büller HR; Department of Vascular Medicine Amsterdam UMC Amsterdam Cardiovascular Sciences University of Amsterdam Amsterdam The Netherlands.
  • Middeldorp S; Department of Internal Medicine Tergooi Hospital Hilversum The Netherlands.
Res Pract Thromb Haemost ; 5(1): 223-230, 2021 Jan.
Article em En | MEDLINE | ID: mdl-33537547
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Idioma: En Revista: Res Pract Thromb Haemost Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Idioma: En Revista: Res Pract Thromb Haemost Ano de publicação: 2021 Tipo de documento: Article